1. Home
  2. List
Reference Patent

Reference - List

When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 51 Hits
  • Search Condition : Filter (MeSH = Deoxycytidine / pharmacology)
Species Resource Title
Human and Animal Cells TGBC2TKB(RCB1130) GLI2 but not GLI1/GLI3 plays a central role in the induction of malignant phenotype of gallbladder cancer.
Human and Animal Cells MOLT-4(RCB0206) 2-Chloro-2'-deoxyadenosine induces apoptosis through the Fas/Fas ligand pathway in human leukemia cell line MOLT-4.
Human and Animal Cells HuCCT1(RCB1960) Histone deacetylase inhibitor enhances the anti-tumor effect of gemcitabine: a special reference to gene-expression microarray analysis.
Human and Animal Cells TGBC1TKB(RCB1129) , TGBC2TKB(RCB1130) Guggulsterone enhances antitumor activity of gemcitabine in gallbladder cancer cells through suppression of NF-κB.
Human and Animal Cells MCF7(RCB1904) Gemcitabine treatment enhances HER2 expression in low HER2-expressing breast cancer cells and enhances the antitumor effects of trastuzumab emtansine.
Human and Animal Cells HuCCT1(RCB1960) , HuH-28(RCB1943) , TFK-1(RCB2537) , TKKK(RCB1907) , TGBC2TKB(RCB1130) , TGBC14TKB(RCB1186) , TGBC18TKB(RCB1169) Establishment and biological characterization of a novel cell line derived from hepatoid adenocarcinoma originated at the ampulla of Vater.
Human and Animal Cells HuCCT1(RCB1960) , SSP-25(RCB1293) , RBE(RCB1292) , YSCCC(RCB1549) , TGBC24TKB(RCB1196) , TFK-1(RCB2537) Synergistic antiproliferative effects of an mTOR inhibitor (rad001) plus gemcitabine on cholangiocarcinoma by decreasing choline kinase activity.
DNA material PINK1_WT-IRES-GFP-NLS (RDB18946) , PINK1_KD-IRES-GFP-NLS (RDB18947) , MUL1_WT-IRES-GFP-NLS (RDB18948) , MUL1_LD-IRES-GFP-NLS (RDB18949) Gemcitabine induces Parkin-independent mitophagy through mitochondrial-resident E3 ligase MUL1-mediated stabilization of PINK1.
Human and Animal Cells HS-Sch-2(RCB2230) , YST-1(RCB2136) , HS-PSS(RCB2362) Drug sensitivity and resistance testing identifies PLK1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumors.
Human and Animal Cells MIA Paca2(RCB2094) Ribonucleotide reductase is an effective target to overcome gemcitabine resistance in gemcitabine-resistant pancreatic cancer cells with dual resistant factors.
Human and Animal Cells TFK-1(RCB2537) , HuCCT1(RCB1960) Overexpression of karyopherin-α2 in cholangiocarcinoma correlates with poor prognosis and gemcitabine sensitivity via nuclear translocation of DNA repair proteins.
Human and Animal Cells MBT-2(RCB0544) Combination Treatment of the Oral CHK1 Inhibitor, SRA737, and Low-Dose Gemcitabine Enhances the Effect of Programmed Death Ligand 1 Blockade by Modulating the Immune Microenvironment in SCLC.
Human and Animal Cells RERF-LC-AI(RCB0444) , RERF-LC-KJ(RCB1313) , LC-2/ad(RCB0440) , A549 Contrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR Tyrosine Kinase Inhibitor Gefitinib on NK Cell-Mediated Cytotoxicity via Regulation of NKG2D Ligand in Non-Small-Cell Lung Cancer Cells.
Human and Animal Cells KP4(RCB1005) Dual Inhibition of IGF-1R and ErbB3 Enhances the Activity of Gemcitabine and Nab-Paclitaxel in Preclinical Models of Pancreatic Cancer.
Human and Animal Cells BOY-12E(RCB2627) , JMSU1(RCB2227) ASP5878, a selective FGFR inhibitor, to treat FGFR3-dependent urothelial cancer with or without chemoresistance.
Human and Animal Cells HuCCT1(RCB1960) , HuH-28(RCB1943) Anoikis-resistant cholangiocarcinoma cells display aggressive characteristics and increase STAT3 activation.
Human and Animal Cells RBE(RCB1292) , HuCCT1(RCB1960) , SSP-25(RCB1293) , TGBC24TKB(RCB1196) , TFK-1(RCB2537) ATM Inhibitor Suppresses Gemcitabine-Resistant BTC Growth in a Polymerase θ Deficiency-Dependent Manner.
Human and Animal Cells A549(RCB0098) Rho-Associated Protein Kinase (ROCK) Inhibitors Inhibit Survivin Expression and Sensitize Pancreatic Cancer Stem Cells to Gemcitabine.
Human and Animal Cells ACC-MESO-1(RCB2292) , ACC-MESO-4(RCB2293) Functional Genomic Screen in Mesothelioma Reveals that Loss of Function of BRCA1-Associated Protein 1 Induces Chemoresistance to Ribonucleotide Reductase Inhibition.
Human and Animal Cells G-415(RCB2640) , TGBC1TKB(RCB1129) , TGBC2TKB(RCB1130) Functional and genomic characterization of three novel cell lines derived from a metastatic gallbladder cancer tumor.